HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bowman Cox

Executive Editor

Washington, DC
Bowman Cox leads the Pink Sheet's coverage of pharmaceutical manufacturing quality issues. He writes and edits articles on the challenges and opportunities that developments in science, technology and regulatory policy pose to drug manufacturers and their quality organizations.

Latest From Bowman Cox

Special Counsel Finds US FDA’s Dismissal Of Inspection Concerns Unreasonable

Agency biologics investigator questioned site classification downgrades and belated response to Merck & Co. plant informant’s concerns.

Quality Compliance

Biden Infrastructure Plan Would Boost Pandemic Preparedness, Biotech R&D, US Manufacturing

Tax hike would fund $30bn for pandemic preparations and billions more for biotech R&D and rural manufacturing jobs that are part of comprehensive infrastructure renewal proposal.

Manufacturing Research & Development

BARDA To Help Expand Manufacture Of Supplies Needed To Produce COVID-19 Vaccines

Agency requests proposals to boost surge capacity for single-use bags, tubing sets, vials, raw materials, vaccine plants.

Coronavirus COVID-19 Manufacturing

FDA CDER Compliance Office Answered Pandemic With Fewer Inspections, Greater Discretion

Fewer inspections but more warning letters, import alerts and drug-shortage discretions were seen as office sought to ameliorate COVID-19 impacts.

Manufacturing Quality

US FDA Explores Pandemic Inspection Alternatives, Post-Pandemic Strategies

Agency's Janet Woodcock  and Judy McMeekin say the FDA is looking at options like livestream plant videos while preparing to address backlog after inspections can resume.

FDA Manufacturing

When You Can’t Win For Losing: Kodak And The Reshoring Of US Pharmaceutical Manufacturing

Kodak, Fujifilm and startups Civica Rx and Phlow fight with grit, vision and government support to restore US pharmaceutical manufacturing.

Business Strategies Ingredients
See All
UsernamePublicRestriction

Register